Aciclovir (oral or intravenous) for treatment vs placebo
Relief of pain · Patients being treated for cancer with established oral HSV infection (bone marrow transplant recipients / immunocompromised)
1 finding from 1 review
- Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer 2009 · Cochrane All outcomesTime to first decrease in pain was significantly shorter in favour of oral aciclovir (median 3 days versus 16 days, P = 0.04; Shepp 1985). Time to complete resolution of pain was shorter with oral aciclovir than…2 studiesGRADE not reported